Thursday 15 September 2022
Venue: Utrecht Science Park, Lecture hall C1.02, Androclus building, Yalelaan 1, Utrecht
Deadline for registration: Thursday 1 September 2022
The theme of the 2022 edition will be Lessons learnt from COVID-19 Vaccination.
Previous editions covered topics like Vaccines and pathogen adaptation, Development of a COVID-19 vaccine, Structural Vaccinology, Novel Vaccine Platforms, The powerful contribution of vectors to vaccine-induced immunity, Vaccination in the Elderly, Maternal vaccination, Vector-borne diseases, Vaccines and re-emerging infections and Innovative vector approaches in vaccination.
The symposium will be open for all interested at no charge, it is however necessary to register below.
Cécile van Els, RIVM & Biomolecular Health Sciences, Veterinary Medicine, Utrecht University
Rogier Sanders, Medical Microbiology and Infection Prevention, Amsterdam UMC
"Structural Vaccine Design for Spike Protein-based vaccines"
Rory de Vries, Viroscience, Erasmus Medical Center, Rotterdam
“Humoral and cellular immune mechanisms induced by COVID-19 vaccines: cross-reactivity against Variants of Concern?”
Corine Geurts van Kessel, Viroscience, Erasmus Medical Center, Rotterdam
“Switching of COVID-19 vaccines in prime-boost schedules; a practical solution or strategy to optimize effectiveness?”
Dinja Oosterhoff, Intravacc, Bilthoven
“Improving Covid-19 vaccination: vaccine candidates inducing Mucosal Immunity”
Daniel L. Hurdiss, Biomolecular Health Sciences, Veterinary Medicine, Utrecht University
“Mapping vulnerable sites on the SARS-CoV-2 spike protein”
Sophie Bots, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
“The art of rapid safety evaluation studies in the context of COVID-19 vaccines; balancing a need for speed with reliable and robust research”
Mirte Pascha,Section Viorology, Veterinary Faculty, Utrecht University
“Mosaic N1 and N2 neuraminidase nanoparticles induce high antibody titers and potent protection from Influenza A virus H1N1 and H3N2 challenge”
Linda van Oosten, Laboratory of Virology, Wageningen University & Research
“A two-component S1-nanoparticle vaccine protects against SARS-CoV-2 challenge in K18-hACE2 mice”
Sebastiaan de Graaf, Bijvoet Center for Biomolecular Research, Utrecht University
“Exploring the human milk IgA1 response to SARS-CoV-2 vaccination at the clonal level”
|End of the symposium|